Next-Gen Covid-19 Vaccines and Drugs Crowd into Late-Stage Trials
Despite the widespread rollout of vaccines over 2021, the Covid-19 pandemic remains a threat to…
15/02/2022 - 7 minutes
Sanofi
Sanofi Joins AI Gold Rush in €4.6B Drug Discovery Pact with Exscientia
As big pharma companies flock to drug discovery collaborations with artificial intelligence (AI) firms, the…
11/01/2022 - 4 minutes
The Future of Diabetes Treatment: Is a Cure Possible?
Diabetes has become an epidemic, sentencing over 460 million people worldwide to lifelong medication. Science…
15/11/2021 - 10 minutes
Kiadis’ Natural Killer Cell Therapies Earn €308M Acquisition by Sanofi
The French big pharma Sanofi has offered €308M to acquire the Dutch firm Kiadis Pharma…
03/11/2020 - 3 minutes
Could mRNA Vaccines Fulfill Their Potential Against Coronavirus?
The first vaccine against coronavirus disease could one day be made of mRNA. How is…
30/03/2020 - 7 minutes
Update: Janssen and Maze Jump on Board Finnish Genomics Project
Update (25/02/2020): Janssen and the US company Maze Therapeutics are the latest pharma companies to…
25/02/2020 - 3 minutes
European Project Launches to Tailor Autoimmune Disease Treatments
Public and private organizations across Europe will pool their resources in an €80M project to…
31/10/2019 - 2 minutes
Sanofi Obtains License for French Company’s Antibody Engineering Platform
Sanofi has signed a licensing deal with French biotech Biomunex, whose antibody technology has the potential…
15/01/2019 - 2 minutes
Sanofi Invests €80M in mRNA Cancer Vaccine Company
Sanofi is to make an €80M equity investment in the German biotech BioNTech, and the two…
07/01/2019 - 3 minutes
How to Close a €3.9B Acquisition Deal for Your Biotech Company
Ablynx, one of the big giants in the European biotech arena, closed the final stages…
30/05/2018 - 7 minutes
Evotec Takes Over Sanofi’s Infectious Disease Pipeline
Evotec will be getting over 10 assets, €60M upfront and about 100 scientists from Sanofi's…
08/03/2018 - 2 minutes
Novo Nordisk Gets Close to Launching the First Oral GLP-1 Drug for Diabetes
Novo Nordisk has positive Phase III trial results for its oral version of semaglutide, a…
23/02/2018 - 3 minutes
